.On the heels of a $3 billion fund from Bain Funding Life Sciences, Arc Venture Partners is actually...
.Finnish biotech Orion has snooped possible in Aitia's "electronic double" technician to create bran...
.While Windtree Therapeutics has battled to grow the financial roots needed to endure, a period 2 wi...
.OncoC4 is taking AcroImmune-- as well as its in-house clinical manufacturing capacities-- under its...
.Amgen has discussed (PDF) the initial period 3 records on its own $400 thousand dermatitis medicati...
.Biogen and also UCB's rely on improving right into period 3 on the back of an unsuccessful research...
.Italian biotech Aptadir Therapies has released along with the pledge that its own pipeline of precl...
.Surge Life Sciences has actually met its own target in a Duchenne muscle dystrophy (DMD) study, ins...
.After a few years in biotech, Mike Quigley, Ph.D., is actually returning to the pharma layer, occup...
.Achilles Rehabs has shreded its own approach. The British biotech is quiting working on its clinica...